[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

[Asia Economy Reporter Ji Yeon-jin] JinMatrix has been showing a surge of over 10% for three consecutive trading days following news of the spread of monkeypox.


As of 9:45 AM on the 2nd, JinMatrix was trading at 8,970 KRW, up 13.37% (1,060 KRW) compared to the previous trading day. The company also rose 16.20% and 18.89% on the 30th and 31st of last month, respectively.


The recent sharp rise is interpreted as reflecting the highlighted potential for new drug development amid the global spread of infectious diseases such as monkeypox.



JinMatrix is a company engaged in molecular diagnostics for genetic analysis and personalized medicine, researching and developing diagnostic agents, medical devices, and new drug-related technologies including vaccines and natural products to prevent diseases.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing